Close Menu

On Stage and in Song

As part of his 2012 TedMed talk, the US National Institutes of Health Director Francis Collins says that the time between understanding the molecular cause of a disease and developing a drug to treat that disease is too long, and the process is too expensive. Collins further suggests that drugs that have been shown to be safe in humans — though not effective for their original target diseases — could be repurposed for other diseases, as the new National Center for Advancing Translational Sciences is aiming to do.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Reuters reports that Germany is seeking to sequence 5 percent of patient samples that test positive for SARS-CoV-2.

23andMe and Medscape say primary care physicians are increasingly more comfortable with discussing direct-to-consumer genetic testing results.

The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories.

In Science this week: analysis of genome-wide association studies of chronic kidney disease, and more.